Tiansheng Pharmaceutical Group Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 257.68 million compared to CNY 487.87 million a year ago. Revenue was CNY 270.35 million compared to CNY 495 million a year ago.

Net loss was CNY 46.49 million compared to CNY 40.48 million a year ago. Basic loss per share from continuing operations was CNY 0.1462 compared to CNY 0.1273 a year ago. Diluted loss per share from continuing operations was CNY 0.1462 compared to CNY 0.1273 a year ago.